Trubion Pharmaceuticals
Seattle
About Trubion Pharmaceuticals
Trubion Pharmaceuticals is a biopharmaceutical company creating a pipeline of product candidates to treat autoimmune disease and cancer. Our product candidates are novel proteins known as single-chain polypeptides and are designed using our SMIPTM custom drug assembly technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 101 – 250
- Total funding: $55.6M
- Funding stage: M&A
- Last round: Post-IPO Equity (Sep 2009)
- Ticker: nasdaq:TRBN
- Website: trubion.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/trubion-pharmaceuticals-526727 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.